Merit Medical Systems (NASDAQ:MMSI) Rating Increased to Hold at BidaskClub

BidaskClub upgraded shares of Merit Medical Systems (NASDAQ:MMSI) from a sell rating to a hold rating in a report released on Thursday, January 18th.

A number of other equities analysts also recently issued reports on MMSI. ValuEngine downgraded Merit Medical Systems from a buy rating to a hold rating in a research report on Friday, December 1st. Canaccord Genuity reiterated a buy rating and issued a $45.00 target price on shares of Merit Medical Systems in a report on Sunday, October 8th. Zacks Investment Research downgraded Merit Medical Systems from a buy rating to a hold rating in a report on Tuesday, October 3rd. SunTrust Banks set a $47.00 price objective on Merit Medical Systems and gave the company a buy rating in a report on Thursday, November 16th. Finally, Wells Fargo & Co restated an outperform rating and set a $51.00 price objective (up previously from $46.00) on shares of Merit Medical Systems in a report on Thursday, November 30th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and ten have issued a buy rating to the company. The stock presently has a consensus rating of Buy and a consensus price target of $43.77.

Shares of Merit Medical Systems (MMSI) opened at $43.25 on Thursday. Merit Medical Systems has a 12 month low of $27.25 and a 12 month high of $48.10. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.43 and a current ratio of 2.78. The company has a market capitalization of $2,140.98, a PE ratio of 70.90, a PEG ratio of 2.53 and a beta of 1.29.

In other Merit Medical Systems news, Director Franklin J. Miller sold 10,000 shares of the business’s stock in a transaction on Friday, December 29th. The stock was sold at an average price of $43.93, for a total value of $439,300.00. Following the sale, the director now directly owns 21,244 shares in the company, valued at $933,248.92. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Kent W. Stanger sold 9,082 shares of the business’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $44.90, for a total value of $407,781.80. The disclosure for this sale can be found here. In the last three months, insiders sold 32,000 shares of company stock worth $1,416,379. Insiders own 5.00% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Virtus Fund Advisers LLC bought a new stake in shares of Merit Medical Systems during the 4th quarter valued at $160,000. Ameritas Investment Partners Inc. raised its stake in shares of Merit Medical Systems by 20.9% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock valued at $163,000 after purchasing an additional 738 shares during the period. SG Americas Securities LLC bought a new stake in shares of Merit Medical Systems during the 3rd quarter valued at $189,000. Riverhead Capital Management LLC raised its stake in shares of Merit Medical Systems by 67.7% during the 2nd quarter. Riverhead Capital Management LLC now owns 5,198 shares of the medical instruments supplier’s stock valued at $198,000 after purchasing an additional 2,098 shares during the period. Finally, Flinton Capital Management LLC increased its stake in Merit Medical Systems by 67.4% in the 2nd quarter. Flinton Capital Management LLC now owns 5,236 shares of the medical instruments supplier’s stock worth $200,000 after acquiring an additional 2,108 shares during the last quarter. Institutional investors own 87.44% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Merit Medical Systems (NASDAQ:MMSI) Rating Increased to Hold at BidaskClub” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/02/13/merit-medical-systems-mmsi-lifted-to-hold-at-bidaskclub.html.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Analyst Recommendations for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply